Pallas Capital Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,366
Closed -$251K 893
2025
Q4
$251K Sell
2,366
-213
-8% -$24.7K 0.01% 747
2025
Q3
$328K Buy
2,579
+180
+8% +$21.4K 0.01% 650
2025
Q2
$294K Buy
2,399
+22
+0.9% +$2.51K 0.01% 662
2025
Q1
$241K Sell
2,377
-189
-7% -$18.5K 0.01% 642
2024
Q4
$237K Buy
+2,566
New +$252K 0.01% 521

Other funds holding EHC

Pallas Capital Advisors's EHC Position: Q1 2026 in Review

Pallas Capital Advisors sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 2,366 shares — an estimated $251K sold.

Pallas Capital Advisors first reported a position in EHC in Q4 2024 and held it in 5 quarters. The position peaked at $328K in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Pallas Capital Advisors reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Pallas Capital Advisors sold 2,366 Encompass Health shares in Q1 2026, an estimated $251K.
  • Pallas Capital Advisors first reported a position in Encompass Health in Q4 2024 and held it in 5 quarters.
  • Pallas Capital Advisors's Encompass Health position peaked at $328K in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.